Related references
Note: Only part of the references are listed.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
CD24: A Rheostat That Modulates Cell Surface Receptor Signaling of Diverse Receptors
D. Craig Ayre et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2016)
Predictive Levels of CD24 in Peripheral Blood Leukocytes for the Early Detection of Colorectal Adenomas and Adenocarcinomas
Sarah Kraus et al.
DISEASE MARKERS (2015)
CD24 and APC Genetic Polymorphisms in Pancreatic Cancers as Potential Biomarkers for Clinical Outcome
Sivan Shamai et al.
PLOS ONE (2015)
Associations between CD24 gene polymorphisms and inflammatory bowel disease: A meta-analysis
Xiao-Li Huang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
CD24 knockout prevents colorectal cancer in chemically induced colon carcinogenesis and in APCMin/CD24 double knockout transgenic mice
Inna Naumov et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Role of CD24 polymorphisms in the susceptibility to inflammatory bowel disease
Victoria Lisiansky et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2014)
CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer
Frederik Marme et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Analysis of the influence of two CD24 genetic variants in Crohn's disease and ulcerative colitis
Lina-Marcela Diaz-Gallo et al.
HUMAN IMMUNOLOGY (2011)
CD24, a Novel Cancer Biomarker, Predicting Disease-Free Survival of Non-small Cell Lung Carcinomas A Retrospective Study of Prognostic Factor Analysis from the Viewpoint of Forthcoming (Seventh) New TNM Classification
Hyun Ju Lee et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Targeting CD24 for treatment of colorectal and pancreatic cancer by monoclonal antibodies or small interfering RNA
Eyal Sagiv et al.
CANCER RESEARCH (2008)
A dinucleotide deletion in CD24 confers protection against autoimmune diseases
Lizhong Wang et al.
PLOS GENETICS (2007)
CD24 is a new oncogene, early at the multistep process-of colorectal cancer carcinogenesis
Eyal Sagiv et al.
GASTROENTEROLOGY (2006)
CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis
P Baumann et al.
CANCER RESEARCH (2005)
CD24 and human carcinoma: tumor biological aspects
SC Lim
BIOMEDICINE & PHARMACOTHERAPY (2005)
Expression of CD24 in adenocarcinomas of the pancreas correlates with higher tumor grades
J Jacob et al.
PANCREATOLOGY (2004)
CD24 is a genetic modifier for risk and progression of multiple sclerosis
QM Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Share Paper
